High-Throughput Screen Identifying the Thiosemicarbazone N5C319726 Compound as a Potent Antimicrobial Lead Against Resistant Strains of Escherichia coli

被引:5
作者
Sadaka, Carmen [1 ]
Damborg, Peter [2 ]
Watts, Jeffrey L. [2 ]
机构
[1] Univ Copenhagen, Dept Vet & Anim Sci, Stigboejlen 4, DK-1870 Frederiksberg C, Denmark
[2] Zoetis Global Therapeut Res, 333 Portage St, Kalamazoo, MI 49007 USA
来源
BIOMOLECULES | 2018年 / 8卷 / 04期
关键词
sulfonamide resistance; antifolate; Escherichia coli; antimicrobial lead; drug discovery; multidrug resistance; DRUG-DISCOVERY; AGREEMENT; ANTIBIOTICS;
D O I
10.3390/biom8040166
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antibiotic discovery is vital when considering the increasing antimicrobial resistance threat. The aim of this work was to provide a high-throughput screen (HTS) assay using multidrug-resistant Escherichia coli strains to enable further research into antimicrobial lead discovery and identify novel antimicrobials. This study describes a primary HTS of a diverse library of 7884 small molecules against a susceptible E. coli strain. A secondary screening of 112 molecules against four E. coli strains with different susceptibility profiles revealed NSC319726 as a potential antimicrobial lead serving as a novel template. NSC319726 is a good candidate for an analoguing program.
引用
收藏
页数:8
相关论文
共 21 条
  • [1] A novel validated assay to support the discovery of new anti-malarial gametocytocidal agents
    Bahamontes-Rosa, Noemi
    Gomez-Lorenzo, Maria G.
    Lelievre, Joel
    Rodriguez Alejandre, Ane
    Jesus Almela, Maria
    Lozano, Sonia
    Herreros, Esperanza
    Gamo, Francisco-Javier
    [J]. MALARIA JOURNAL, 2016, 15
  • [2] Ball AR, 2012, ADV M C M, P7, DOI 10.1079/9781845939434.0007
  • [3] Oxazolidinone structure-activity relationships leading to linezolid
    Barbachyn, MR
    Ford, CW
    [J]. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (18) : 2010 - 2023
  • [4] Can biotech deliver new antibiotics?
    Barrett, JF
    [J]. CURRENT OPINION IN MICROBIOLOGY, 2005, 8 (05) : 498 - 503
  • [5] Agreement between methods of measurement with multiple observations per individual
    Bland, J. Martin
    Altman, Douglas G.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (04) : 571 - 582
  • [6] Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
  • [7] STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT
    BLAND, JM
    ALTMAN, DG
    [J]. LANCET, 1986, 1 (8476) : 307 - 310
  • [8] Antibiotics in the clinical pipeline in 2011
    Butler, Mark S.
    Cooper, Matthew A.
    [J]. JOURNAL OF ANTIBIOTICS, 2011, 64 (06) : 413 - 425
  • [9] CLSI, 2008, DEV IN VITR SUSC TES, V3rd
  • [10] CLSI, 2013, PERFORMANCE STANDARD, V4th ed.